ZULRESSO

This brand name is authorized in United States.

Active ingredients

The drug ZULRESSO contains one active pharmaceutical ingredient (API):

1
Brexanolone
UNII S39XZ5QV8Y - BREXANOLONE
 

Brexanolone is indicated for the treatment of postpartum depression (PPD) in adults. The mechanism of action is not fully understood, but is thought to be related to its positive allosteric modulation of GABAA receptors.

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ZULRESSO Solution for injection MPI, US: SPL/PLR FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
US FDA, National Drug Code 72152-547

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈